Human Urinary Kallidinogenase Suppresses Cerebral Inflammation in Experimental Stroke and Downregulates Nuclear Factor-κB

[1]  M. Kaps,et al.  Edema formation in the hyperacute phase of ischemic stroke. Laboratory investigation. , 2009, Journal of neurosurgery.

[2]  L. J. Eldik,et al.  Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NFκB and MAPK dependent pathways in rat astrocytes , 2009, Brain Research.

[3]  Zhi-bin Chen,et al.  Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1. , 2009, European journal of pharmacology.

[4]  Yu-ping Peng,et al.  Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK , 2009, Neuroscience Letters.

[5]  L. Chao,et al.  Tissue Kallikrein Elicits Cardioprotection by Direct Kinin B2 Receptor Activation Independent of Kinin Formation , 2008, Hypertension.

[6]  Q. Hou,et al.  Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and the peri-infarction region and improves neurological function after focal cortical infarction in hypertensive rats , 2008, Brain Research.

[7]  E. Warburton,et al.  Inflammation and ischaemic stroke , 2007, Current opinion in neurology.

[8]  J. Hanoune.  Role of cocaine and amphetamine regulated transcript in estradiol-mediated neuroprotection. , 2007 .

[9]  Qing Wang,et al.  The inflammatory response in stroke , 2007, Journal of Neuroimmunology.

[10]  J. Simard,et al.  Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications , 2007, The Lancet Neurology.

[11]  N. Plesnila,et al.  Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats , 2006, Neurochemistry International.

[12]  J. Mocco,et al.  Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia , 2006, Circulation research.

[13]  R. Vemuganti,et al.  Prevention of inflammation is a mechanism of preconditioning-induced neuroprotection against focal cerebral ischemia , 2006, Neurochemistry International.

[14]  L. Chao,et al.  The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction , 2006, Biological chemistry.

[15]  L. Chao,et al.  Experimental therapy with tissue kallikrein against cerebral ischemia. , 2006, Frontiers in bioscience : a journal and virtual library.

[16]  L. Chao,et al.  Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. , 2006, Human gene therapy.

[17]  Gang Wang,et al.  Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity , 2006, Nature Medicine.

[18]  M. T. Hasan,et al.  IKK mediates ischemia-induced neuronal death , 2005, Nature Medicine.

[19]  N. Plesnila,et al.  Release of Bradykinin and Expression of Kinin B2 Receptors in the Brain: Role for Cell Death and Brain Edema Formation After Focal Cerebral Ischemia in Mice , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  L. Chao,et al.  Kallikrein–kinin in stroke, cardiovascular and renal disease , 2005, Experimental physiology.

[21]  E. Connolly,et al.  Anti-adhesion molecule strategies as potential neuroprotective agents in cerebral ischemia: A critical review of the literature , 2004, Inflammation Research.

[22]  L. Chao,et al.  Kallikrein Gene Transfer Protects Against Ischemic Stroke by Promoting Glial Cell Migration and Inhibiting Apoptosis , 2004, Hypertension.

[23]  C. Iadecola,et al.  Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia , 2003, Brain Research.

[24]  N. Plesnila,et al.  Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia , 2002, Brain Research.

[25]  V. Perry,et al.  Monocyte Chemoattractant Protein-1 Deficiency is Protective in a Murine Stroke Model , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  T. Maniatis,et al.  NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .

[27]  M. Chopp,et al.  Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats , 2001, Stroke.

[28]  E. Mackenzie,et al.  Ischemia-Induced Interleukin-6 as a Potential Endogenous Neuroprotective Cytokine against NMDA Receptor-Mediated Excitoxicity in the Brain , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  W. R. Taylor,et al.  Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[30]  吉田 英昭.  Kallikrein Gene Delivery Attenuates Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion , 2000 .

[31]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[32]  L. Chao,et al.  Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats. , 1999, Stroke.

[33]  F. Barone,et al.  Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  M. Ross,et al.  Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage , 1997, The Journal of Neuroscience.

[35]  N. Rothwell,et al.  Cytokines and acute neurodegeneration , 1997, Molecular Psychiatry.

[36]  M. Ross,et al.  Inducible Nitric Oxide Synthase Gene Expression in Brain following Cerebral Ischemia , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  T. Yue,et al.  Expression of Interleukin-6, c-Fos, and zif268 mRNAs in Rat Ischemic Cortex , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  E. Benveniste,et al.  Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. , 1995, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience.

[39]  C. Iadecola,et al.  Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. , 1995, The American journal of physiology.

[40]  T. Tomoguri,et al.  [Pharmacological studies on human urinary kallidinogenase (SK-827): effects on cerebral metabolism]. , 1993, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.